• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:李力,肖昌钱,朱逢佳,廉洪,韩奇,刘炜.LC-MS/MS测定人血浆中阿罗洛尔浓度[J].中国现代应用药学,2014,31(12):1496-1499.
LI Li,XIAO Changqian,ZHU Fengjia,LIAN Hong,HAN Qi,LIU Wei.Determination of Arotinolol Concentration in Human Plasma by LC-MS/MS[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(12):1496-1499.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2509次   下载 2241 本文二维码信息
码上扫一扫!
分享到: 微信 更多
LC-MS/MS测定人血浆中阿罗洛尔浓度
李力, 肖昌钱, 朱逢佳, 廉洪, 韩奇, 刘炜
浙江医院药剂科,杭州 310013
摘要:
目的 建立LC- MS/MS方法测定人血浆中阿罗洛尔的浓度。方法 人血浆样品用乙酸乙酯提取后,选用ZORBAX Extend C18(2.1 mm×100 mm,3.5 mm)色谱柱,以乙腈-水(80∶20,含0.1%甲酸)为流动相,流速为0.30 mL·min-1,采用电喷雾离子化源,正离子方式,多反应监测(MRM)扫描方式进行监测,用于定量分析的离子反应分别为m/z372.3→315.9(阿罗洛尔)和m/z 267.2→145.0(内标阿替洛尔)。结果 血浆中阿罗洛尔的线性范围为0.5~1 000 ng·mL-1(r=0.995 2),定量下限为0.5 ng·mL-1;日内、日间RSD均<15%; 低、中、高3 个浓度的提取回收率分别为(80.6±1.6)%,(83.2±3.1)%和(87.5±4.5)%。结论 该方法快速、灵敏、准确,专属性强,重复性好,适用于人血浆中阿罗洛尔浓度的测定,可应用于阿罗洛尔的血药浓度检测和药动学研究。
关键词:  阿罗洛尔  液质联用  血药浓度  药动学
DOI:
分类号:R917
基金项目:“重大新药创制”科技重大专项(2013ZX09303005);国家自然科学基金(31201040)
Determination of Arotinolol Concentration in Human Plasma by LC-MS/MS
LI Li, XIAO Changqian, ZHU Fengjia, LIAN Hong, HAN Qi, LIU Wei
Department of Pharmacy, Zhejiang Hospital, Hangzhou 310013, China
Abstract:
OBJECTIVE To develop a LC-MS/MS method for determination of arotinolol concentration in human-plasma. METHODS The plasma samples were processed with ethyl acetate extraction and separated on ZORBAX Extend C18 column (2.1 mm×100 mm, 3.5 μm) and eluted with acetonitrile-water (80∶20, containing 0.1% formic acid). Detection of the analyte was achieved using positive ion electrospray ionization (ESI) in the multiple reaction monitoring (MRM) mode. The MS/MS ion transitions monitored were m/z 372.3→m/z 315.9 and m/z 267.2→m/z 145.0 for arotinolol and internal standard, respectively. RESULTS The linear calibration curve of arotinolol was obtained concentration range of 0.5-1 000 ng·mL-1(r=0.995 2), with the lower limit of quantitation of 0.5 ng·mL-1. Intra-day and inter-day relative standard deviations were both <15%. The recoveries of low, middle and high concentrations were (80.6±1.6)%, (83.2±3.1)% and (87.5±4.5)%, respectively. CONCLUSION The established method is rapid, sensitive, accurate, specific and reliable, and suitable for the determination of arotinolol in human plasma and pharmacokinetic study.
Key words:  arotinolol  LC-MS/MS  plasma drug concentration  pharmacokinetics
扫一扫关注本刊微信